Insider Trades61 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 30,000 | $17.96 | $4.0B | -23.14% | +191.97% | $538.9K | -7.44% | 10b5-1 | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 6,461 | $14.58 | $4.0B | -23.14% | +191.97% | $94.2K | -3.68% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 6,844 | $14.52 | $4.0B | -23.14% | +191.97% | $99.4K | -4.84% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 7,909 | $14.52 | $4.0B | -23.14% | +191.97% | $114.9K | -4.56% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 29,282 | $14.47 | $4.0B | -23.14% | +191.97% | $423.8K | -0.87% | — | Buy Now |
| Mar 2, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 29,282 | $14.48 | $4.0B | -23.14% | +191.97% | $424.1K | -0.87% | — | Buy Now |
| Feb 23, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 3,419 | $14.14 | $4.0B | -23.14% | +191.97% | $48.4K | -2.36% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 3,448 | $14.65 | $4.0B | -23.14% | +191.97% | $50.5K | -2.33% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 3,557 | $14.65 | $4.0B | -23.14% | +191.97% | $52.1K | -2.01% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 15,500 | $14.68 | $4.0B | -23.14% | +191.97% | $227.6K | -0.46% | — | Buy Now |
| Feb 2, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 15,500 | $14.69 | $4.0B | -23.14% | +191.97% | $227.6K | -0.46% | — | Buy Now |
| Jan 15, 2026 | Buy | AMLX | Justin B. Klee | Co-Chief Executive Officer | 338,188 | $10.03 | $4.0B | -23.14% | +191.97% | $3.4M | +0.45% | — | Buy Now |
| Jan 15, 2026 | Buy | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 338,167 | $10.03 | $4.0B | -23.14% | +191.97% | $3.4M | +0.45% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | James M Frates | Chief Financial Officer | 3,326 | $11.11 | $4.0B | -23.14% | +191.97% | $37.0K | -1.84% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 7,715 | $11.09 | $4.0B | -23.14% | +191.97% | $85.6K | -0.23% | — | Buy Now |
| Jan 6, 2026 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 7,715 | $11.09 | $4.0B | -23.14% | +191.97% | $85.6K | -0.23% | — | Buy Now |
| Dec 1, 2025 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 6,580 | $14.35 | $4.0B | -23.14% | +191.97% | $94.4K | -3.61% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 8,828 | $14.58 | $4.0B | -23.14% | +191.97% | $128.7K | -5.62% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | James M Frates | Chief Financial Officer | 10,558 | $14.65 | $4.0B | -23.14% | +191.97% | $154.7K | -3.63% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 12,039 | $14.58 | $4.0B | -23.14% | +191.97% | $175.5K | -6.19% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 29,933 | $14.35 | $4.0B | -23.14% | +191.97% | $429.5K | -0.45% | — | Buy Now |
| Sep 30, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 29,975 | $14.38 | $4.0B | -23.14% | +191.97% | $431.0K | -0.45% | — | Buy Now |
| Aug 12, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 30,000 | $8.20 | $4.0B | -23.14% | +191.97% | $246.1K | -8.36% | 10b5-1 | Buy Now |
| May 22, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 1,000 | $5.36 | $4.0B | -23.14% | +191.97% | $5.4K | -0.53% | — | Buy Now |
| Mar 31, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 9,192 | $3.48 | $4.0B | -23.14% | +191.97% | $32.0K | -4.66% | — | Buy Now |
| Mar 31, 2025 | Sell | AMLX | James M Frates | Chief Financial Officer | 10,896 | $3.47 | $4.0B | -23.14% | +191.97% | $37.8K | -3.61% | — | Buy Now |
| Mar 31, 2025 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 12,425 | $3.47 | $4.0B | -23.14% | +191.97% | $43.1K | -6.01% | — | Buy Now |
| Mar 31, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 21,490 | $3.46 | $4.0B | -23.14% | +191.97% | $74.5K | -0.64% | — | Buy Now |
| Mar 31, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 21,490 | $3.47 | $4.0B | -23.14% | +191.97% | $74.5K | -0.64% | — | Buy Now |
| Mar 3, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 1,611 | $3.12 | $4.0B | -23.14% | +191.97% | $5.0K | -1.19% | — | Buy Now |
| Mar 3, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 4,595 | $3.15 | $4.0B | -23.14% | +191.97% | $14.5K | -0.14% | — | Buy Now |
| Mar 3, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 4,595 | $3.17 | $4.0B | -23.14% | +191.97% | $14.5K | -0.14% | — | Buy Now |
| Feb 24, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 4,169 | $3.15 | $4.0B | -23.14% | +191.97% | $13.1K | -3.00% | — | Buy Now |
| Feb 5, 2025 | Buy | AMLX | Justin B. Klee | Co-Chief Executive Officer | 36,310 | $1.57 | $4.0B | -23.14% | +191.97% | $57.0K | +1.15% | — | Buy Now |
| Feb 3, 2025 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 3,678 | $3.49 | $4.0B | -23.14% | +191.97% | $12.8K | -2.58% | — | Buy Now |
| Feb 3, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 11,855 | $3.47 | $4.0B | -23.14% | +191.97% | $41.1K | -0.37% | — | Buy Now |
| Feb 3, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 11,851 | $3.47 | $4.0B | -23.14% | +191.97% | $41.1K | -0.37% | — | Buy Now |
| Jan 6, 2025 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 7,471 | $4.04 | $4.0B | -23.14% | +191.97% | $30.2K | -0.23% | — | Buy Now |
| Jan 6, 2025 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 7,471 | $4.05 | $4.0B | -23.14% | +191.97% | $30.2K | -0.23% | — | Buy Now |
| Dec 2, 2024 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 5,421 | $5.54 | $4.0B | -23.14% | +191.97% | $30.0K | -3.77% | — | Buy Now |
| Nov 4, 2024 | Buy | AMLX | Justin B. Klee | Co-Chief Executive Officer | 63,690 | $1.57 | $4.0B | -23.14% | +191.97% | $100.0K | +2.02% | — | Buy Now |
| Sep 30, 2024 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 8,709 | $3.20 | $4.0B | -23.14% | +191.97% | $27.8K | -5.75% | — | Buy Now |
| Sep 30, 2024 | Sell | AMLX | Camille L Bedrosian | Chief Medical Officer | 11,442 | $3.20 | $4.0B | -23.14% | +191.97% | $36.6K | -7.37% | — | Buy Now |
| Sep 30, 2024 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 18,589 | $3.20 | $4.0B | -23.14% | +191.97% | $59.4K | -0.57% | — | Buy Now |
| Sep 30, 2024 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 18,589 | $3.20 | $4.0B | -23.14% | +191.97% | $59.4K | -0.59% | — | Buy Now |
| Sep 23, 2024 | Buy | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 1,857 | $1.57 | $4.0B | -23.14% | +191.97% | $2.9K | +0.06% | — | Buy Now |
| Sep 12, 2024 | Buy | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 34,449 | $1.57 | $4.0B | -23.14% | +191.97% | $54.1K | +1.07% | — | Buy Now |
| Sep 12, 2024 | Buy | AMLX | James M Frates | Chief Financial Officer | 40,000 | $2.53 | $4.0B | -23.14% | +191.97% | $101.4K | +20.68% | — | Buy Now |
| May 15, 2024 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 10,455 | $1.88 | $4.0B | -23.14% | +191.97% | $19.7K | -6.46% | 10b5-1 | Buy Now |
| Mar 5, 2024 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 1,540 | $18.73 | $4.0B | -23.14% | +191.97% | $28.8K | -1.86% | — | Buy Now |
| Mar 5, 2024 | Sell | AMLX | James M Frates | Chief Financial Officer | 1,792 | $18.73 | $4.0B | -23.14% | +191.97% | $33.6K | -1.31% | — | Buy Now |
| Mar 5, 2024 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 4,135 | $18.73 | $4.0B | -23.14% | +191.97% | $77.4K | -0.14% | — | Buy Now |
| Mar 5, 2024 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 4,135 | $18.73 | $4.0B | -23.14% | +191.97% | $77.4K | -0.14% | — | Buy Now |
| Feb 23, 2024 | Sell | AMLX | Gina Mazzariello | Chief Legal Officer | 2,838 | $18.76 | $4.0B | -23.14% | +191.97% | $53.2K | -5.78% | — | Buy Now |
| Jan 9, 2024 | Sell | AMLX | James M Frates | Chief Financial Officer | 2,716 | $16.33 | $4.0B | -23.14% | +191.97% | $44.3K | -2.37% | — | Buy Now |
| Jan 9, 2024 | Sell | AMLX | Patrick D Yeramian | Chief Medical Officer | 2,812 | $16.33 | $4.0B | -23.14% | +191.97% | $45.9K | -1.35% | — | Buy Now |
| Jan 9, 2024 | Sell | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 5,841 | $16.33 | $4.0B | -23.14% | +191.97% | $95.4K | -0.20% | — | Buy Now |
| Jan 9, 2024 | Sell | AMLX | Justin B. Klee | Co-Chief Executive Officer | 5,841 | $16.33 | $4.0B | -23.14% | +191.97% | $95.4K | -0.21% | — | Buy Now |
| Dec 27, 2023 | Buy | AMLX | Margaret Olinger | Chief Commercial Officer | 25,000 | $0.37 | $4.0B | -23.14% | +191.97% | $9.3K | +8.45% | — | Buy Now |
| Nov 16, 2023 | Buy | AMLX | Joshua B Cohen | Co-Chief Executive Officer | 63,694 | $1.57 | $4.0B | -23.14% | +191.97% | $100.0K | +2.21% | — | Buy Now |
| Oct 31, 2023 | Buy | AMLX | James M Frates | Chief Financial Officer | 11,072 | $16.31 | $4.0B | -23.14% | +191.97% | $180.6K | — | — | Buy Now |